Skip to main content
Suneet Grewal, MD, Rheumatology, West Hollywood, CA

Suneet Grewal MD


Physician

Join to View Full Profile
  • 8700 Beverly Blvd# B131West Hollywood, CA 90048

  • Phone+1 310-423-4496

  • Fax+1 510-357-5463

Dr. Grewal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterFellowship, Rheumatology, 2011 - 2013
  • Alameda Health System-Highland Hospital
    Alameda Health System-Highland HospitalResidency, Internal Medicine, 2008 - 2011
  • St. George's University School of Medicine
    St. George's University School of MedicineClass of 2008

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2026
  • Internal Medicine
    National Board of Physicians and Surgeons Internal Medicine
  • Rheumatology
    National Board of Physicians and Surgeons Rheumatology

Awards, Honors, & Recognition

  • Fellow American College of Rheumatology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Data from the MIRROR Randomized Controlled Trial of KRYSTEXXA® (Pegloticase) Injection with Methotrexate Published in Arthritis & Rheumatology
    Data from the MIRROR Randomized Controlled Trial of KRYSTEXXA® (Pegloticase) Injection with Methotrexate Published in Arthritis & RheumatologySeptember 14th, 2022
  • Impact of Uncontrolled Gout on Quality of Life and Importance of Open Dialogue with Patients
    Impact of Uncontrolled Gout on Quality of Life and Importance of Open Dialogue with PatientsJuly 1st, 2021
  • First Patient Enrolls in FORWARD Trial to Evaluate Monthly Dosing of KRYSTEXXA® (Pegloticase Injection) and Methotrexate to Treat Uncontrolled Gout
    First Patient Enrolls in FORWARD Trial to Evaluate Monthly Dosing of KRYSTEXXA® (Pegloticase Injection) and Methotrexate to Treat Uncontrolled GoutMarch 25th, 2021

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: